CD44 and neoplasm: To test this, we monitored the expression of the differentiation markers, CD44 and CD62L, in SIINFEKL-activated CD8+ T cells from OT-1 mice co-cultured with tumor-MDSC or non-suppressive immature myeloid cells (iMC).